Net Worth Advisory Group Has $291,000 Position in Koninklijke Philips (NYSE:PHG)

Net Worth Advisory Group decreased its stake in Koninklijke Philips (NYSE:PHG) by 4.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,481 shares of the technology company’s stock after selling 571 shares during the period. Net Worth Advisory Group’s holdings in Koninklijke Philips were worth $291,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the stock. FMR LLC increased its position in Koninklijke Philips by 0.6% during the 3rd quarter. FMR LLC now owns 6,138,708 shares of the technology company’s stock valued at $200,859,000 after purchasing an additional 35,935 shares during the period. Bank of Montreal Can increased its position in shares of Koninklijke Philips by 2,883.5% during the third quarter. Bank of Montreal Can now owns 982,199 shares of the technology company’s stock worth $32,157,000 after buying an additional 949,278 shares during the period. IHT Wealth Management LLC bought a new position in Koninklijke Philips during the third quarter worth $19,593,000. Raymond James Financial Inc. bought a new position in Koninklijke Philips during the fourth quarter worth $10,655,000. Finally, Bar Harbor Wealth Management boosted its position in Koninklijke Philips by 2.1% during the fourth quarter. Bar Harbor Wealth Management now owns 308,157 shares of the technology company’s stock valued at $7,803,000 after acquiring an additional 6,281 shares during the last quarter. 13.67% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on PHG shares. BNP Paribas upgraded Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research report on Tuesday, February 25th. StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, UBS Group upgraded shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Koninklijke Philips Price Performance

Shares of PHG opened at $26.75 on Wednesday. The stock has a market cap of $25.15 billion, a P/E ratio of -31.85, a P/E/G ratio of 0.82 and a beta of 0.78. The business’s fifty day moving average is $26.57 and its 200 day moving average is $27.92. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59. Koninklijke Philips has a 12-month low of $19.10 and a 12-month high of $32.91.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). The business had revenue of $5.38 billion during the quarter, compared to the consensus estimate of $5.10 billion. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. Sell-side analysts anticipate that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Koninklijke Philips Cuts Dividend

The business also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be issued a dividend of $0.886 per share. This represents a yield of 2.9%. The ex-dividend date of this dividend is Tuesday, May 13th. Koninklijke Philips’s dividend payout ratio is currently -89.29%.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.